Phase 1 Study to Investigate Effect of Rifampin and Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy Subjects | 百济神州

⟵ Back to Search Results

Phase 1 Study to Investigate Effect of Rifampin and Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy Subjects

Beigene Study ID

BGB-3111-104

ClinicalTrials.gov ID

NCT03301181

Study Overview

Sex: All

Age: 18 Years to 65 Years (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents

Study Overview

Sex: All

Age: 18 Years to 65 Years (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents